| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |